HealthCap
Venture capitalStockholm · Seed–Growth · 30 people tracked
Also known as HEALTHCAP ADVISOR AB · HEALTHCAP IX ADVISOR AB · HEALTHCAP VII ADVISOR AB · HEALTHCAP VIII ADVISOR AB
Investment thesis
HealthCap invests in and helps build life science companies developing breakthrough therapies with a high unmet medical need. It focuses on emerging therapeutics, particularly targeted treatments for rare diseases, cancers, and genetic diseases. The firm emphasizes deep medical expertise across medicine, finance, and biochemistry, and aims to challenge existing medical paradigms to find new ways to treat or cure diseases and improve quality of life. HealthCap stresses a responsible and sustainable approach to investing and ownership, collaborating with investors, academia, portfolio companies, patients, and other societal stakeholders to create long-term value and positive impact.
Source: firm website, verified Aug 11, 2026.
Team · 30 people
from the firm's website & public directories
What they invest in
from 24 of 35 portfolio companiesBiotech ×17Healthtech ×15Medical Devices ×9Digital Health ×4AgTech ×1AI & Machine Learning ×1Deep Tech ×1FoodTech ×1
HQs:United States×8Finland×1France×1Sweden×1
Investments · 35 tracked
founders shown can be your intro pathBy year:2025 · 12020 · 12017 · 12015 · 25 dated
Pulmonx develops the Zephyr Valve, a bronchoscopic medical device for treating severe COPD and emphysema without surgery.
HealthtechMedical DevicesSan Jose, US
GLENDON E. FRENCH(Executive Officer, Director)DANA G. MEAD, JR(Director)STEPHEN SALMON(Director)RODNEY PERKINS, M.D.(Director)OERN STUGE(Director)MICHAEL MATLY(Director)
Board seatStaffan Lindstrand· per SEC Form D
BiotechSouth San Francisco, US
Javier Szwarcberg(Executive Officer, Director)Samir Gharib(Executive Officer)RICHARD KING(Executive Officer, Director)CAMILLA SIMPSON(Director)
BoardSimpson Camilla(Director)Tiba Aynechi(Director)
Board seatJonas Hansson· per SEC Form D
BiotechDoylestown, US
John P. Hamill(Executive Officer)Oren Gilad(Executive Officer, Director)
BoardJean-Pierre Bizzari(Director)Gabriela Gruia(Director)Rifat Pamukcu(Director)Bernd Seizinger(Director)
Hemab is a biotechnology company developing targeted prophylactic therapies for people with serious bleeding and blood coagulation disorders that lack adequate treatment options.
BiotechHealthtech
Incardatherapeutics develops drug therapies for treating atrial fibrillation using synergistic combinations of anti-arrhythmic agents, with delivery platforms designed for both hospital and at-home settings.
BiotechDigital HealthMedical DevicesBrisbane, US
Rangachari Narasimhan(Executive Officer, Director)McCarthy Reenie(Director)Grace Colon(Executive Officer, Director)Bischofberger Norbert(Director)Miller Samantha(Executive Officer)
Board seatJohan Christenson· per SEC Form D
BiotechRaleigh, US
Robert Seltzer(Director)Jaikrishna Patel(Executive Officer)Marco Taglietti(Director)Pierre Legault(Executive Officer, Director)James Mitchum(Director)John Hamill(Executive Officer)
Board seatEugen Steiner· per SEC Form D · $28.5M raise · filed Nov 2015
Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need.
BiotechMedical Devices
AMRA Medical provides MRI-based body composition analytics that generate fat and muscle biomarkers for clinical trials and clinical decision-making.
AI & Machine LearningHealthtechMedical Devices
RxList is an online drug information reference that provides details on prescription medications, drug classifications, comparisons, vitamins and supplements.
Digital HealthHealthtechMedia & Entertainment
BiotechPhiladelphia, US
Susan B Dillon(Executive Officer, Director)Karyn O'Neil(Executive Officer, Director)Mark V. Laurenzi(Executive Officer)Elizabeth Anderson(Director)
BoardBruce Peacock(Director)
BiotechPhiladelphia, US
Steven Kelly(Executive Officer, Director)Margarita Chavez(Director)Eran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)
CurifyLabs develops an automated compounding system for pharmacies that uses robotics, GMP-manufactured excipient bases, and integrated quality control software to enable faster, safer preparation of customized medications.
Digital HealthHealthtechMedical DevicesHelsinki, FI
Charlotta TopeliusNiklas Sandler Topelius
Fusion Pharma develops targeted alpha therapeutics for cancer treatment using proprietary linker technology to connect alpha-emitting medical isotopes to cancer-targeting molecules, delivering lethal damage to tumor cells while minimizing toxicity to healthy tissues.
BiotechHealthtechMedical Devices
BiotechSouth San Francisco, US
Yael Weiss(Executive Officer, Director)
BoardCamille Samuels(Director)Marten Steen(Director)Shalini Sharp(Director)Stephen Farr(Director)
Neobiomics develops dietary supplement products, including ProPrems and NeoMega36, aimed at supporting the health and development of preterm infants, such as normal vision function.
BiotechFoodTechHealthtech
Oncorena is developing orellanine as a potential treatment for metastatic renal cell carcinoma and is running a clinical trial to evaluate its safety, tolerability, and anti-tumor efficacy in patients with metastatic clear-cell or papillary renal cell carcinoma.
BiotechHealthtech
Aerogen develops vibrating mesh nebuliser technology for aerosol drug delivery used across critical care, emergency care, and ventilated and non-ventilated respiratory therapies.
HealthtechMedical Devices
Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.
BiotechDeep TechHealthtechMedical Devices
Michal Minczuk(Co-Founder)Gabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)Maria Falkenberg(Co-Founder)Nils-Göran Larsson(Co-Founder)Jay Parrish(Chief Executive Officer & Chairman of the Board)
SynOx Therapeutics develops treatments for people with tenosynovial giant cell tumours (TGCT) and other macrophage-mediated diseases.
BiotechHealthtech
Vicore Pharma is a clinical-stage biopharmaceutical company developing treatments for diseases in which the AT2 (angiotensin II type 2) receptor plays a central role.
BiotechHealthtech
Vivet Therapeutics is a company focused on gene and cell therapy development, presenting research at major scientific conferences.
BiotechParis, FR
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 4
IPOs and acquisitions across the tracked portfolioPulmonx Corp.NASDAQ: LUNGSpruce BiosciencesNASDAQ: SPRBAprea TherapeuticsNASDAQ: APREHemab TherapeuticsNASDAQ: COAG
Portfolio news
latest coverage across their companiesPulmonx Corp. · defenseworld.net · Jul 19, 2026
Adcendo · geekwire.com · Jul 13, 2026
CurifyLabs · mobihealthnews.com · Jul 7, 2026
Pretzel Therapeutics · nasdaqprivatemarket.com · Aug 3, 2025
Frequently asked questions
- What stage does HealthCap invest at?
- HealthCap invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does HealthCap focus on?
- HealthCap focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is HealthCap located?
- HealthCap is headquartered in Stockholm, SE.
Media · Podcasts & interviews
featuring the teamHealthcare Direkt v.49: Varför är styrelsen viktig? Gäst: Staffan Lindstrand, Partner Healthcap
Direkt Studios · Staffan Lindstrand
Images
Co-investors · 10
Ysios Capital is a life sciences investor that finances innovative biotech companies worldwide, providing resources to develop novel therapies for indications with high unmet medical needs.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.
RA Capital invests in public and private healthcare and life science companies developing pharmaceuticals, medical devices, and diagnostic tools. The firm operates as a crossover fund across multiple investment stages.
Cambridge Innovation Capital (CIC) is a UK-based venture capital firm backing entrepreneurs in life sciences and deep tech, leveraging its position in the Cambridge science and technology ecosystem.
Abingworth is a life science venture capital firm that backs early-stage biopharma and biotech companies, helping entrepreneurs translate scientific discoveries into new therapeutics.
.jpeg)
Vida Ventures is a life sciences venture capital firm focused on transforming biomedical innovations into therapies that improve patients' lives.
Earlybird Venture Capital is a European venture capital firm that backs early-stage technology founders with capital, strategic support, and access to an international network.
Pureos Bioventures is a venture capital firm that invests in private, innovative drug development companies, with a focus on next-generation biological drugs and drug formats to treat severe diseases.
Firms observed investing alongside HealthCap, from public investor directories. Shared companies are the overlap with HealthCap's recorded portfolio.
Similar investors
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.